Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
批准号:
8588296
负责人:
NANCY SPECK
金额:
$32.2万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2015-12-31
关键词:
Acute Myelocytic LeukemiaAgeAgingAgonistApoptosisBlood CellsBone Marrow TransplantationCell LineageCell ProliferationCell physiologyCellsCollectionCommitCore-Binding FactorCytokine ReceptorsDNA BindingDefectDevelopmentDiseaseDrug TargetingDysmyelopoietic SyndromesEngraftmentFetal LiverGenesGoalsHematological DiseaseHematopoieticHematopoietic stem cellsIncidenceLifeMegakaryocytesMicroRNAsMolecularMultipotent Stem CellsMusMutationMyelogenousPatientsPhenotypePopulationProductionProliferatingPropertyProteinsRUNX1 geneRefractory Anemia with Excess Blasts in TransformationRefractory anaemia with excess blastsRegulationSLAM proteinSignal TransductionStagingStem cellsStudy modelsUnited Statesbasecytokinehuman MPL proteinimprovedmigrationprogenitorpublic health relevancestemtherapeutic targettranscription factor
中文摘要
描述(申请人提供):这项建议的目的是阐明RUNX1在造血干细胞和祖细胞中的缺失改变它们的功能,并促进骨髓增生异常综合征(MDS)和急性髓系白血病(AML)的发展的机制。RUNX1的失活突变在分化最低的M0亚型的AML患者和MDS患者中发现的比例很高。MDS是一组血液疾病的集合,其特征是一个或多个血细胞系的产生效率低下,目前除了骨髓移植外,还没有治愈的方法。在小鼠中RUNX1的丢失似乎概括了MDS的早期阶段,因此是研究RUNX1功能受损如何促进这种疾病发展的模型。我们发现RUNX1的缺失会导致造血干细胞和多能祖细胞更频繁地增殖,大约2000个基因和40个microRNAs的表达在这些人群中发生了变化。在这里,我们建议描述由RUNX1缺陷引起的造血干细胞和祖细胞的缺陷。我们将研究在RUNX1缺陷的HSCs中表达异常的基因是否与这些缺陷有关。我们将确定用一种表达不足的细胞因子受体激动剂治疗小鼠是否能改善植入性。最后,我们将评估几个microRNAs对与RUNX1缺乏相关的植入缺陷的贡献,以及它们导致MDS的能力。
英文摘要
DESCRIPTION (provided by applicant): The goal of this proposal is to elucidate the mechanisms by which loss of Runx1 in hematopoietic stem and progenitor cells alters their function, and contributes to the development of myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML). Inactivating mutations in RUNX1 are found in a high percentage of patients with AML of the least differentiated M0 subtype, and in MDS. MDS is a collection of blood disorders characterized by the inefficient production of one or more blood cell lineages, for which there is currently no cure aside from bone marrow transplantation. Loss of Runx1 in mice appears to recapitulate early stages of MDS, and is therefore a model for studying how impaired Runx1 function contributes to the development of this disease. We showed that loss of Runx1 causes hematopoietic stem cells and multipotent progenitors to proliferate more frequently, and that the expression of approximately 2000 genes and 40 microRNAs is altered in these populations. Here we propose to characterize the defects in HSCs and progenitors caused by Runx1 deficiency. We will examine whether genes whose expression is dysregulated in Runx1 deficient HSCs contribute to these defects. We will determine if treatment of mice with an agonist of a cytokine receptor that is under-expressed improves engraftment. Finally we will assess the contribution of several microRNAs to the engraftment defects associated with Runx1 deficiency, and their ability to cause MDS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Repressing TGFbeta family signaling to promote hematopoietic stem cell formation in the embryo
-
批准号:10589924
-
项目类别:
-
资助金额:$34.32万
-
财政年份:2022
-
负责人:NANCY SPECK
-
依托单位:
Mechanisms of endothelial-to-hemogenic transition mediated by Runx1
-
批准号:9922673
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2017
-
负责人:NANCY SPECK
-
依托单位:
CD27:CD70 signaling in hematopoietic stem cell formation
-
批准号:9374787
-
项目类别:
-
资助金额:$20.78万
-
财政年份:2017
-
负责人:NANCY SPECK
-
依托单位:
Mechanisms of endothelial-to-hemogenic transition mediated by Runx1
-
批准号:9547467
-
项目类别:
-
资助金额:$47.17万
-
财政年份:2017
-
负责人:NANCY SPECK
-
依托单位:
Mechanisms of endothelial-to-hemogenic transition mediated by Runx1
-
批准号:10183274
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2017
-
负责人:NANCY SPECK
-
依托单位:
Epigenetic landscapes of embryonic lymphoid progenitors and HSCs
-
批准号:9061765
-
项目类别:
-
资助金额:$23.17万
-
财政年份:2015
-
负责人:NANCY SPECK
-
依托单位:
Epigenetic landscapes of embryonic lymphoid progenitors and HSCs
-
批准号:8891754
-
项目类别:
-
资助金额:$20.92万
-
财政年份:2015
-
负责人:NANCY SPECK
-
依托单位:
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
-
批准号:8782253
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:NANCY SPECK
-
依托单位:
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
-
批准号:8050470
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:NANCY SPECK
-
依托单位:
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
-
批准号:8208990
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:NANCY SPECK
-
依托单位:
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
-
批准号:8408770
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2011
-
负责人:NANCY SPECK
-
依托单位:
FASEB Conference-Hematological Malignancies
-
批准号:7001073
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:NANCY SPECK
-
依托单位:
Runx1 as a Marker for Stem Sells
-
批准号:6798311
-
项目类别:
-
资助金额:$45.06万
-
财政年份:2003
-
负责人:NANCY SPECK
-
依托单位:
Runx1 as a Marker for Stem Sells
-
批准号:6579275
-
项目类别:
-
资助金额:$16.04万
-
财政年份:2003
-
负责人:NANCY SPECK
-
依托单位:
Runx1 as a Marker for Stem Sells
-
批准号:6838248
-
项目类别:
-
资助金额:$46.27万
-
财政年份:2003
-
负责人:NANCY SPECK
-
依托单位:
Runx1 as a Marker for Stem Sells
-
批准号:7009258
-
项目类别:
-
资助金额:$46.39万
-
财政年份:2003
-
负责人:NANCY SPECK
-
依托单位:
MOUSE MODELS FOR FAMILIAL PLATELET DISORDER
-
批准号:6692649
-
项目类别:
-
资助金额:$29.48万
-
财政年份:2001
-
负责人:NANCY SPECK
-
依托单位:
MOUSE MODELS FOR FAMILIAL PLATELET DISORDER
-
批准号:6626790
-
项目类别:
-
资助金额:$31.45万
-
财政年份:2001
-
负责人:NANCY SPECK
-
依托单位:
MOUSE MODELS FOR FAMILIAL PLATELET DISORDER
-
批准号:6231273
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2001
-
负责人:NANCY SPECK
-
依托单位:
MOUSE MODELS FOR FAMILIAL PLATELET DISORDER
-
批准号:6489414
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2001
-
负责人:NANCY SPECK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: